SCHOTT Pharma AG & Co. reported third quarter net income of 46 million euros, flat with prior year. Earnings per share was 0.30 euros compared to 0.31 euros. EBITDA was 83 million euros, an increase of 11%, on both a reported and at constant currency basis. EBITDA margin was 32.4% as reported and 31.7% at constant currencies.
Third quarter revenues increased by 1% to 256 million euros, which corresponds to a 3% year-over-year growth at constant currencies.
Organic revenue growth for fiscal 2025 is expected to be around 6.0%. The EBITDA margin is expected to be around 28.0%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.